|
Index of reports
> Cases resulting in hospitalization (4)
Below is the selection of adverse event reports related to Amerge (Naratriptan) that includes cases resulting in hospitalization.
Adverse event in female receiving Amerge (Naratriptan)
Reported by a consumer/non-health professional from United States on 2007-07-12
Patient: female
Adverse reactions / side effects: Arteriospasm Coronary, Cardiomyopathy
Adverse event resulted in: hospitalization
Suspect drug(s):
Amerge
Administration route: Oral
Indication: Migraine
Imitrex
Administration route: Oral
Indication: Migraine
Axert
Indication: Migraine
Frova
Relpax
Adverse event in female receiving Amerge (Naratriptan)
Reported by a consumer/non-health professional from United States on 2007-06-28
Patient: female
Adverse reactions / side effects: Arteriospasm Coronary, Cardiomyopathy
Adverse event resulted in: hospitalization
Suspect drug(s):
Amerge
Administration route: Oral
Indication: Migraine
Imitrex
Administration route: Oral
Indication: Migraine
Frova
Relpax
Adverse event in 49 year old female receiving Amerge (Naratriptan)
Reported by a individual with unspecified qualification from Germany on 2007-05-07
Patient: 49 year old female
Adverse reactions / side effects: Hepatitis Viral, Autoimmune Hepatitis, Chronic Hepatitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Amerge
Dosage: twice per day
Indication: Migraine
Start date: 2006-12-01
End date: 2006-12-01
Rizatriptan Benzoate
Ibuprofen
Dosage: as required
Indication: Migraine
Adverse event in female receiving Amerge (Naratriptan)
Reported by a pharmacist from Canada on 2007-04-12
Patient: female
Adverse reactions / side effects: Cardiac Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Amerge (Naratriptan)
|
